文献速递心力衰竭与心肌病

中国心内科医生对心力衰竭铁缺乏的认知与管理差距:全国调查

Gaps in knowledge and management of iron deficiency in heart failure: a nationwide survey of cardiologists in China.
PubMed 文献 · Heart · 2025-04-10

一项面向中国各省心内科医生的独立学术网络调查显示,共1342名医生完成问卷。超过半数不了解心衰患者需筛查铁缺乏且未常规筛查,约80%不熟悉诊断标准,仅0.8%将转铁蛋白饱和度<20%视为独立指标;仅14%倾向静脉铁而非口服铁。主要障碍为知识与经验不足,但多数医生有兴趣学习。

要点

  • 超过半数中国心内科医生不了解心衰铁缺乏筛查需求且未常规筛查。
  • 约80%不熟悉铁缺乏诊断标准,仅0.8%识别转铁蛋白饱和度<20%为独立指标。
  • 仅14%倾向静脉铁,多数对静脉铁剂量计算及指南推荐药物不熟悉。

核心结论

  • 中国心内科医生在心衰铁缺乏的认知和管理方面存在较大差距。

研究设计与样本

  • 独立学术网络调查,通过社交网络分发至中国各省心内科医生,共1342名完成(中位年龄34岁,IQR 30-39,51%女性)。

主要发现

  • 超过半数不了解心衰需筛查铁缺乏且未常规筛查。
  • 约80%不熟悉心衰铁缺乏诊断标准,仅0.8%识别转铁蛋白饱和度<20%为独立指标。
  • 仅14%倾向静脉铁而非口服铁,68%倾向口服铁。
  • 四分之三不熟悉静脉铁剂量计算方法。
  • 超过80%不了解当前指南仅推荐羧基麦芽糖铁或异麦芽糖酐铁用于纠正铁缺乏。

关键数值与推荐

  • 指南推荐心衰患者常规检测铁缺乏,左心室射血分数<50%者若存在铁缺乏应静脉补铁。
  • 仅0.8%医生识别转铁蛋白饱和度<20%为铁缺乏独立指标。
  • 仅14%医生倾向静脉铁而非口服铁。
  • 超过80%医生不了解指南仅推荐羧基麦芽糖铁或异麦芽糖酐铁纠正铁缺乏。

临床怎么用

  • 需加强心内科医生对心衰铁缺乏筛查、诊断标准及静脉铁治疗的继续教育。
  • 多数医生有兴趣学习心衰铁缺乏管理,可据此设计教育项目。

局限性

  • 原文未报告调查的抽样方法、应答率及代表性限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heart failure (HF) guidelines recommend routine testing for iron deficiency (ID) and, for those with ID, intravenous iron if the left ventricular ejection fraction is <50%. Guideline adherence to these recommendations by cardiologists in China is unknown. METHODS AND RESULTS: An independent academic web-based survey was designed and distributed via social networks to cardiologists across China. Overall, 1342 cardiologists (median age 34 years, IQR 30-39, 51% women) from all provinces of China completed this survey. More than half were unaware of the need to screen for ID in HF and did not do so routinely in their clinical practice. Approximately 80% were not familiar with the diagnostic criteria for ID in HF guidelines, and only 0.8% recognised transferrin saturation <20% as an independent marker of ID. Regarding iron repletion, only 14% preferred intravenous to oral iron for correcting ID compared with 68% favouring oral iron. Three-quarters were unfamiliar with methods for calculating intravenous iron dose. Furthermore, over 80% were unaware that current guidelines only recommend ferric carboxymaltose or ferric derisomaltose for correcting ID. The main barriers to using intravenous iron were lack of knowledge and experience. Despite such poor awareness and practice, most cardiologists were interested in learning more about managing ID in HF. CONCLUSIONS: In this nationwide survey of cardiologists in China, we identified large gaps in both knowledge and management of ID. This survey will help guide the development of educational programmes to improve care for patients with HF and ID in China.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Su, Li, Li, et al. Gaps in knowledge and management of iron deficiency in heart failure: a nationwide survey of cardiologists in China. Heart. 2025. PMID: 39788722. doi:10.1136/heartjnl-2024-324887

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。